Search research articles
Contact Us
Filters
Showing results (401-410 of 443) with videos related to
Page
of 45
Sort By:
Molecular Psychiatry
|
May 9, 2020
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
Michelle Kokkinou, Elaine E Irvine, David R Bonsall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 2, 2026
Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
ACS Chemical Neuroscience
|
October 23, 2018
Comment on " In Vivo [<sup>18</sup>F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates"
Colm J McGinnity, Erik Årstad, Katherine Beck, et al.
Psychological Medicine
|
April 12, 2017
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A Demjaha, J M Lappin, D Stahl, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
Emma Butler, Toby Pillinger, Kirsten Brown, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 13, 2019
Serotonin release measured in the human brain: a PET study with [<sup>11</sup>C]CIMBI-36 and d-amphetamine challenge
David Erritzoe, Abhishekh H Ashok, Graham E Searle, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 23, 2025
The effects of dopamine receptor antagonist and partial agonist antipsychotics on the glutamatergic system: double-blind, randomised, placebo-controlled <sup>1</sup>H-MRS cross-over study in healthy volunteers
Uzma Zahid, Martin Osugo, Pierluigi Selvaggi, et al.
Human Brain Mapping
|
October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
George Gifford, Nicolas Crossley, Sarah Morgan, et al.
Page
of 45
Search research articles
Search
Showing results (401-410 of 443) with videos related to
Sort By:
Page
of 45
Molecular Psychiatry
|
May 9, 2020
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
Michelle Kokkinou, Elaine E Irvine, David R Bonsall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 2, 2026
Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
ACS Chemical Neuroscience
|
October 23, 2018
Comment on " In Vivo [<sup>18</sup>F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates"
Colm J McGinnity, Erik Årstad, Katherine Beck, et al.
Psychological Medicine
|
April 12, 2017
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A Demjaha, J M Lappin, D Stahl, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
Emma Butler, Toby Pillinger, Kirsten Brown, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 13, 2019
Serotonin release measured in the human brain: a PET study with [<sup>11</sup>C]CIMBI-36 and d-amphetamine challenge
David Erritzoe, Abhishekh H Ashok, Graham E Searle, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 23, 2025
The effects of dopamine receptor antagonist and partial agonist antipsychotics on the glutamatergic system: double-blind, randomised, placebo-controlled <sup>1</sup>H-MRS cross-over study in healthy volunteers
Uzma Zahid, Martin Osugo, Pierluigi Selvaggi, et al.
Human Brain Mapping
|
October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
George Gifford, Nicolas Crossley, Sarah Morgan, et al.
Page
of 45